TET2 and cancer: Epigenetic modifications, particularly aberrant methylation of cancer-related genes such as Tet methylcytosine dioxygenase 2 (TET2) and DNA methyltransferase 3A (DNMT3A), are common abnormalities in MDS (Hosono, 2019).